Work

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

Year: 2018

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2018.11.076

Authors: Lauren M. Hook, Sita Awasthi, Jonathan Dubin, Jessica Flechtner, Deborah Long, Harvey M. Friedman

Institutions: University of Pennsylvania, Genocea (United States)

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases

Awards: HSV-2 immune evasion as a virulence factor, Blocking immune evasion as a novel immunotherapy for recurrent HSV-2 infection, G3765360276, Penn Center for AIDS Research

OpenAlex ID: W2904936785

FWCI: 2.145

Cites: 25

Cited by: 30

Related to: 10